BYON3521

· Byondis B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BYON3521, covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521 [Phase 1]